Internal report on J&J quality meltdown due this month; 3PL Triplefin chooses Manhattan for new DCs;

> A J&J internal report of Tylenol manufacturing problems over the past year should be completed later this month, says CEO Bill Weldon. Article (registration required)

> Third party logistics provider Triplefin has implemented the SCALE (Supply Chain Architected for Logistics Execution) solutions from Manhattan Associates at two new distribution centers in Cincinnati. Triplefin release

> DSM Pharma Chemicals has launched the InnoSyn manufacturing route scouting services to help clients achieve cost savings by reducing synthesis steps and redesigning synthesis routes. DSM release

> AstraZeneca has tapped Aurobindo Pharma to supply solid dosage and sterile products for emerging markets. Item 

> Drug formulator Bend Research is expanding its manufacturing capabilities for hot-melt extrusion. Bend Research release

Suggested Articles

A biotech that worked with a nutritional products maker on the API for its clinical-stage radiation drug, is buying all of the manufacturing know-how.

Merck KGaA is selling a manufacturing site and its Allergopharma allergy drug business as it focuses on newer meds.

In a first, the FDA and Indian oversight agencies worked together to block illegal drugs from entering the U.S.